Great Point Partners’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-280,000	Closed	-$6.77M	–	37
2020 Q2	$6.77M	Buy	+280,000	New	+$6.77M	0.54%	28